Key facts
- This page summarizes Jason W. Myers's Form 4 filing for IsoPlexis Corp.
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 21 Mar 2023, 16:53.
Jason W. Myers - 21 Mar 2023 Form 4 Insider Report for IsoPlexis Corp
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 21 Mar 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 21 Mar 2023, 16:53:55 UTC
- Prior SEC filing
- 21 Jun 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jason W. Myers
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Jason W. Myers filed Form 4 for IsoPlexis Corp on 21 Mar 2023.
Change
- Previous filing in this sequence was filed on 21 Jun 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ISO
transaction
Derivative
Stock Option
Disposed to Issuer
- Transaction value
- Shares
- -40,000
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 21 Mar 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 40,000
- Exercise price
- $10.72
- Footnotes
- F1, F2
ISO
transaction
Derivative
Stock Option
Disposed to Issuer
- Transaction value
- Shares
- -89,047
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 21 Mar 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 89,047
- Exercise price
- $2.10
- Footnotes
- F1, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Jason W. Myers is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 3 footnotes
Footnote F1
On March 21, 2023, pursuant to the Agreement and Plan of Merger, dated as of December 21, 2022 (the Merger Agreement), by and among IsoPlexis Corporation, a Delaware corporation (IsoPlexis), Berkeley Lights, Inc., a Delaware corporation (Berkeley Lights), and Iceland Merger Sub Inc., a Delaware corporation and a wholly owned subsidiary of Berkeley Lights, each IsoPlexis stock option reported in this Form 4 that was (a) vested and unexercised or (b) vested solely as a result of the consummation of the merger pursuant to the Merger Agreement was, in each case, exercisable prior to the effective time of such merger and, to the extent unexercised at such effective time, canceled for no consideration.
Footnote F2
Vested 25% on July 19, 2022 and thereafter in 36 equal monthly installments.
Footnote F3
Vests in full on the earlier of June 16, 2023 or the day prior to the next annual stockholders meeting.